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ABSTRACT
Objectives: The primary aim of this prospective study
was to perform a comprehensive serial characterisation
of monocyte and neutrophil function, circulating
monocyte subsets, and bronchoalveolar lavage (BAL)
fluid after lung resection. A secondary aim was to
perform a pilot, hypothesis-generating evaluation of
whether innate immune parameters were associated
with postoperative pneumonia.
Methods: Forty patients undergoing lung resection
were studied in detail. Blood monocytes and
neutrophils were isolated preoperatively and at 6, 24
and 48 h postoperatively. BAL was performed
preoperatively and immediately postoperatively.
Monocyte subsets, monocyte responsiveness to
lipopolysaccharide (LPS) and neutrophil phagocytic
capacity were quantified at all time points. Differential
cell count, protein and cytokine concentrations were
measured in BAL. Pneumonia evaluation at 72 h was
assessed using predefined criteria.
Results: After surgery, circulating subsets of classical
and intermediate monocytes increased significantly.
LPS-induced release of proinflammatory cytokines
from monocytes increased significantly and by 48 h a
more proinflammatory profile was found. Neutrophil
phagocytosis demonstrated a small but significant fall.
Factors associated with postoperative pneumonia were:
increased release of specific proinflammatory and anti-
inflammatory cytokines from monocytes; preoperative
neutrophilia; and preoperative BAL cell count.
Conclusions: We conclude that postoperative lung
inflammation is associated with specific changes in the
cellular innate immune response, a better
understanding of which may improve patient selection
and prediction of complications in the future.
INTRODUCTION
In recent years, there has been increasing
recognition of a complex innate immune
response to insults such as sepsis or trauma.
It is generally accepted that such processes
induce not only a systemic inflammatory
response syndrome, but also a compensatory
anti-inflammatory response (CARS).1 2 The
magnitude and duration of both processes
appear to dictate clinical outcomes,
suggesting that a closely coordinated inter-
action between these apparently divergent
responses is beneficial.3
These concepts have largely arisen from
meticulous serial analysis of plasma cyto-
kines. Far less is known about the innate cel-
lular immune response in this context.
Monocytes are known to infiltrate the lung
in a diverse range of inflammatory lung con-
ditions.4–7 Improved methods for phenotypic
characterisation have led to clear demonstra-
tions of distinct subsets of circulating murine
monocytes, and a similar concept has
emerged in humans with the identification
of classical, non-classical and intermediate
monocyte subsets.8–11 Monocyte deactivation
has been associated with adverse outcomes
in patients with sepsis.12–15 However, remark-
ably little is known about serial functional
responses of monocytes and neutrophils
under pathological conditions.
The aim of this study was therefore to
perform the first detailed ‘within-patient’
characterisation of circulating cellular innate
responses after lung resection. The setting of
lung resection was chosen as there is a rela-
tively consistent and controlled level of surgi-
cal trauma, and because thoracic surgery may
be complicated by postoperative infection or
acute lung injury (ALI).16–18 Secondary aims
were: (1) to make preliminary analyses of
KEY MESSAGES
▸ Lung resection is followed by a systemic innate
immune response characterised by an increase
in classical and intermediate monocytes, heigh-
tened pro-inflammatory responsiveness of
monocytes, and reduced neutrophil phagocytic
capacity.
▸ Within 2 hours of lung resection, an inflamma-
tory response evolves in the contralateral lung.
▸ Pre-operative and pre-operative characteristics of
the innate cellular innate immune response
appear to be associated with post-operative lung
inflammation, though these require validation in
future studies.
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whether innate immune dysfunction predicted post-
operative complications (in the form of alveolar consoli-
dation on chest X-ray (CXR) at 72 h) and (2) to take the
unique opportunity to study serial cellular responses in
bronchoalveolar lavage (BAL) fluid from patients having
lung resection.
MATERIALS AND METHODS
Recruitment of patients
Patients referred for thoracic surgery with proven or clinic-
ally suspected lung cancer were enrolled prospectively.
They were excluded if there was evidence of metastatic
disease on routine preoperative staging. All patients were
surgically staged with bronchoscopy and videomediastino-
scopy prior to lung resection. Informed, written consent
was obtained from all patients.
Blood sampling and preparation
Venepuncture was performed preoperatively and at 6, 24
and 48 h postoperatively. Isolation of granulocytes and
mononuclear cells from whole blood was performed at
each time point using dextran sedimentation and percoll
gradient extraction.19 Neutrophil purity in extracted
granulocyte layers was consistently >95%. Monocytes were
positively selected from the mononuclear layer using
magnetic beads labelled with an anti-CD14 antibody
(Miltenyi Biotec, Germany). Using this technique, the
monocyte purity was consistently >90%.
Flow cytometric analysis of monocyte subsets
Five-colour immunofluorescent labelling of the mono-
nuclear layer of freshly prepared blood was performed
(using antibodies specific to HLA-DR, CD14, CD16,
CCR2 and CX3CR1). An unstained sample and five
single stains were used to compensate the data with a
mixture sample containing all five antibodies used to
identify monocyte subsets.
Monocytes were identified by gating on a cell popula-
tion with the characteristic forward scatter and side
scatter. Within this gate, HLA-DR-positive cells were
identified, and relative CD14 and CD16 expression on
these was used to identify the three principal human
monocyte subsets (CD14++CD16− ‘classical’ monocytes;
CD14++CD16+ ‘intermediate’ monocytes; and CD14
+CD16++ ‘non-classical’ monocytes). Antibodies to
CCR2 and CX3CR1 were used to confirm that each of
the three monocyte subsets (identified by the relative
CD14/CD16 expression) had the characteristic expres-
sion profile for these receptors.
Stimulation of monocytes with lipopolysaccharide
Isolated monocytes were stimulated with lipopolysacchar-
ide (LPS) from Escherichia coli 026:B6 (Sigma, UK), final
concentration 154 ng/mL, for 18 h in duplicate in a
24-well Costar plate (Corning, Amsterdam).
Supernatants were collected and frozen at −80°C until
later analysis. Data were adjusted for total protein using
the Bradford method (Sigma, UK).
Phagocytosis by neutrophils
Phagocytosis by freshly prepared neutrophils was evalu-
ated by flow cytometric analysis of neutrophils exposed
to serum-opsonised zymosan (from Saccharomyces cerevi-
siae) preconjugated with Alexa Fluor 594 (Invitrogen,
UK). Following culture in suspension for 30 min, add-
ition of trypan blue (to quench extracellular fluores-
cence) and multiple washes, flow cytometric analysis was
performed (BD Special Order LSR Fortessa, Becton
Dickinson). The data were subsequently analysed using
FlowJo Software (V.7.6.3; TreeStar Inc) with the
unstained sample being used as the basis of the gating
for positive phagocytosis.
Bronchoalveolar lavage
BAL was performed twice in each patient at least 1 week
apart, thereby allowing any BAL-induced inflammation
to recede. The first BAL was performed prior to medias-
tinoscopy, that is, before any form of surgical trauma,
thus serving as a preoperative sample. The second BAL
was performed immediately after lung resection and
served as an early postoperative comparator sample.
BAL was performed in the lung contralateral to the
tumour on both occasions, and a different lobe was
lavaged at the second BAL.
BAL was performed under general anaesthesia using a
standardised technique.20 Quantification of cell counts,
total protein and preparation of cell-free supernatant for
later analysis were performed as described previously.20
Cytokine analysis
Serum and BAL cytokines were analysed using a com-
mercially available Cytometric Bead Array kit (BD
Human Inflammatory Cytokines Kit, Becton Dickinson
Biosciences).
Definition of postoperative pneumonia
Pneumonia was predefined as new alveolar infiltrates on
a CXR at 72 h, reported by an experienced pulmonary
radiologist blinded to study results, plus two from three
of: temperature >38.0°C or <35.5°C; white cell count
>11.0×109/L or <4.0×109/L; and positive microbiology
on sputum culture.
Statistical analysis
Data were analysed using the Minitab 16 Software
(Minitab Inc). Normality of distribution was assessed
using the Anderson-Darling test. Non-normally distribu-
ted data were log10 transformed prior to further analysis.
Postoperative changes were compared using the paired
t test and groups compared using the two-sample
Student t test. A repeated measures ANOVA/ANCOVA
model was created to incorporate analysis of variance
attributable to time points and the pneumonia group.
To determine relative risk, Youden’s test was applied to
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parameters that were significantly higher in patients with
pneumonia to establish the optimal cut-off for predict-
ing pneumonia. The relative risk for each parameter was
then determined using Fisher’s test and the likelihood
ratio calculated. Statistical significance was considered to
be at the p<0.05 level. The statistical programme
GraphPad Prism 5 (GraphPad Software Inc) was used
for this purpose.
RESULTS
Patient characteristics
Fifty-three patients consented to take part, of whom 13
were excluded (7 had lymph node involvement at medias-
tinoscopy, 2 withdrew consent postoperatively, 1 was
deemed medically unfit for resection after staging and 3
were excluded for practical reasons precluding full sample
collection). Demographic and clinical characteristics of
the 40 patients analysed are shown in table 1. Sixteen
patients (40%) had a preoperative diagnosis of chronic
obstructive pulmonary disease. Surgical resection was per-
formed whenever possible via video-assisted thoracoscopic
surgery (VATS) lobectomy (n=26); otherwise, posterolat-
eral thoracotomy (n=14) was performed. Seventeen
patients (42.5%) proved to have adenocarcinoma and 14
(35.0%) had squamous cell carcinoma. Details of final
histological diagnoses and staging are described in the
online supplementary section (table S1).
Response of circulating blood neutrophils and monocytes
to lung resection
As expected, a significant postoperative leucocytosis was
observed (p<0.0005 by ANOVA modelling). This largely
reflected a significant rise in blood neutrophils, but
there was an associated significant rise in monocytes and
a fall in lymphocytes (p<0.0005 for each cell type by
ANOVA modelling).
Table 2 describes the effect of LPS on blood-derived
monocytes. It should be emphasised that these data are
for all cytokines released from circulating CD14-positive
monocytes (ie, no inferences can be drawn in relation to
secretion by monocyte subsets or to intracellular expres-
sion of the cytokines described). It should also be
emphasised that each time point describes the effects of
LPS stimulation—basal levels of cytokine secretion from
preoperative monocytes that were not stimulated with
LPS are shown in the online supplementary section
(table S2). ANOVA modelling revealed a significant post-
operative increase in IL-8 and tumour necrosis factor
(TNF) release from monocytes stimulated with LPS ex
vivo (table 2). By 48 h IL-8, TNF and IL-6 secretion were
increased significantly, and IL-10 secretion decreased sig-
nificantly, suggesting a tendency towards monocytes
exhibiting a more proinflammatory state of
responsiveness.
The response in serum cytokines over the same time
course was subtly different from the response of isolated
monocytes to LPS. In serum, IL-6, IL-8 and IL-10
showed very similar trends, all rising gradually to 24 h,
and returning towards (but not back to) baseline by
48 h (all p<0.0005 by ANOVA modelling; details are
found in the online supplementary section, table S3).
No significant differences were observed in the post-
operative serum levels of IL-1β, IL-12 or TNF.
Surgery was associated with a significant absolute
increase in circulating populations of both classical and
intermediate monocytes postoperatively, with a corre-
sponding non-significant trend towards a reduction in
the number of non-classical monocytes (figure 1A, B).
The increase in classical and intermediate monocytes
appeared to be established by 24 h.
ANOVA modelling revealed a small but statistically sig-
nificant postoperative reduction in the phagocytic cap-
acity of neutrophils in suspension (the percentage of
neutrophils ingesting 2 or more zymosan particles
(expressed as median with IQR in parenthesis) was 84
(73–91) at baseline, 84 (68–90) at 6 h, 79 (64–86) at
24 h, and 79 (63–87) at 48 h; ANOVA for overall trend,
p=0.047).
Pulmonary response to lung resection
Surgery was associated with a significant increase in total
leucocyte count, total protein and levels of IL-1β, IL-6,
IL-8 and IL-10 in BAL fluid retrieved from the contralat-
eral lung in the immediate postoperative period
(table 3). No evidence of infection was found in any of
the BAL fluid cultures at this time point.
Associations with postoperative pneumonia
Fourteen patients (35%) developed postoperative pneu-
monia according to the predefined criteria. There was
Table 1 Patient characteristics
Characteristic
All patients
n=40
Male, n (%) 23 (57.5)
Mean age, years (SD) 66.9 (7.8)
Mean BMI, kg/m2 (SD) 26.6 (4.3)
Current smoker, n (%)* 13 (32.5)
FEV1, % predicted (SD) 87.3 (23.8)
FEV1/FVC, % predicted (SD) 88.5 (13.9)
TCO, % predicted (SD) 72.0 (21.9)
KCO, % predicted (SD) 78.1 (17.6)
Mean thoracoscore (SD) 2.5 (1.7)
Inpatient mortality, n (%) 0 (0)
Median blood loss, mL (IQR) 120 (55–300)
Mean change in blood Hb, g/L (between
pre-op and day 1 post-op values) (SD)
13.8 (10.0)
Mean duration of surgery, minutes (SD) 203 (44.4)
Thoracoscore is a validated scoring system used to predict
outcomes after thoracic surgery.21
*Current or ex-smoker <2 months duration.
BMI, body mass index; FEV1, forced expiratory volume in 1 s;
FVC, forced vital capacity; Hb, haemoglobin; Kco, diffusing
capacity for carbon monoxide, corrected for lung volume;
Post-op, postoperative; Pre-op, postoperative; Tco, diffusing
capacity for carbon monoxide.
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no significant difference in the rate of pneumonia
according to which form of surgery was performed
(35% in patients undergoing VATS, 36% in patients
having thoracotomy). No patients developed ALI/acute
respiratory distress syndrome as measured by published
criteria.22 The only baseline clinical factor associated
with a significant difference between those who did or
did not develop pneumonia was the transfer factor for
carbon monoxide (60.9% predicted in those who devel-
oped pneumonia vs 77.9% predicted in those who did
not, p=0.010). Further details of baseline clinical
characteristics for these two subgroups are found in the
online supplementary section (table S4).
We went on to test whether individual innate immune
parameters were associated with the development of
postoperative pneumonia (table 4 panel A). In general,
serum cytokines were not associated with pneumonia,
and where they were, the proportional difference was
small. Similarly, neutrophil phagocytosis was not asso-
ciated with pneumonia. In contrast, preoperative cell
counts and elements of monocyte responsiveness
appeared to be associated with pneumonia.
To test this further, parameters identified in table 4
panel A were used to establish which had a significant rela-
tive risk for pneumonia (table 4 panel B). In this setting,
relatively higher neutrophils in blood and leucocytes in
BAL appeared to be associated with pneumonia.
Interestingly, relatively higher anti-inflammatory responses
in LPS-stimulated monocytes (IL-12 preoperatively and
IL-10 at 24 h) were associated with pneumonia, with IL-6
being the only proinflammatory cytokine to show an
association.
DISCUSSION
While several studies have assessed the serum cytokine
response after thoracic surgery,23–25 our findings provide
a first detailed, serial characterisation of monocyte and
neutrophil function after lung resection. Elective
surgery provided a particularly useful setting in which to
study innate immune characteristics in the lung and
blood, given the opportunity to obtain a preoperative
baseline. Our data suggest that classical monocytes are
mainly responsible for postoperative monocytosis.
Intermediate monocytes were also significantly
increased, but interestingly non-classical monocytes
appeared to be numerically and proportionally
decreased relative to baseline, at least as far out as 48 h.
Similar numerical changes have been described after
stroke.26 The fate of intermediate monocytes in this
setting remains to be determined—some evidence exists
for this population having inherent plasticity, with the
capacity to become classical or non-classical monocytes
depending on their environment.27 28
We also report a dynamic state of monocyte respon-
siveness to LPS, with IL-8 secretion increased within 6 h,
and a general tendency for a more proinflammatory
cytokine responsiveness to LPS at 48 h. The pattern of
increased LPS-induced IL-8 secretion from monocytes
postoperatively is broadly similar to that described in a
smaller study of mononuclear cells from (non-thoracic)
surgical patients, though we did not observe the increase
in IL-1β described in that study.29 Certainly, our data
suggest that, on average, monocytes have a heightened
proinflammatory response to LPS in the postoperative
period.
In this regard, a number of points are worth making.
First, our data suggest that the monocyte response gen-
erates proinflammatory cytokines from an early stage.
This is broadly reminiscent of the pattern described in
serum. Second, it is intriguing that the relative risk for
pneumonia was most closely associated with monocyte
release of the anti-inflammatory cytokine IL-10 (table 4
panel B). With regard to associations with postoperative
pneumonia, ours was very much a pilot, hypothesis-
generating study, and as such the sample size was too
small (and not designed) to draw conclusions on
whether a relative anti-inflammatory postoperative
monocyte response is predictive of subsequent pneumo-
nia. Nevertheless, IL-10 is differentially expressed by
Table 2 Ex vivo monocyte responsiveness to stimulation with LPS
Cytokine
0 h 6 h 24 h 48 h
ANOVA
p Value
pg/mL/μg pg/mL/μg pg/mL/μg pg/mL/μg
Median (IQR) Median (IQR) Median (IQR) Median (IQR)
IL-8 1334 (915–1923) 2325 (1194–3059)** 2177 (1072–2734) 2409 (1420–2787)** 0.034
IL-6 282 (130–362) 391 (170–580) 395 (146–601) 454 (192–703)* 0.358
TNF 39.2 (25.8–49.6) 40.7 (25.4–69.5) 43.6 (23.8–67.8) 48.1 (34.8–82.4)* 0.028
IL-10 2.14 (1.18–3.52) 2.61 (0.88–5.07) 1.96 (1.02–3.36) 1.63 (0.78–2.77)* 0.122
IL-1β 28.1 (15.5–52.6) 20.1 (11.6–35.1) 23.4 (11.1–73.5) 18.7 (10.8–32.7) 0.291
IL-12 0.17 (0.14–0.26) 0.18 (0.12–0.24) 0.19 (0.13–0.26) 0.16 (0.13–0.26) 0.451
Blood monocytes were isolated at each of the four perioperative time points and stimulated with LPS for 18 h, ie, isolated monocytes were
stimulated once with LPS—no cells received repeated application of LPS. Cytokine concentrations in supernatants were quantified. Data were
adjusted for total protein content. Data are presented as medians and IQR. Data were analysed for trend by ANOVA; individual time points
were assessed relative to the preoperative value by paired Student t test, *p<0.05, **p<0.005. n=40 for all time points except 48 h, where n=38.
ANOVA, analysis of variance; LPS, lipopolysaccharide; TNF, tumour necrosis factor.
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monocyte subsets,30 and has been implicated in driving
monocyte deactivation,31 which in turn is associated with
increased risk of infection.12–15
Our data also suggested that higher preoperative
total cell counts in BAL (predominantly macrophages)
and higher levels of circulating neutrophils are asso-
ciated with a higher risk of postoperative pneumonia.
None of our patients had infection detected in BAL
samples preoperatively. It is tempting to speculate that
patients with a relatively heightened systemic and pul-
monary innate immunity in the preoperative phase
are more susceptible to the ‘second hit’ of surgery,
and/or to low-level postoperative infective inocula,
especially if their monocytes tend to yield a relatively
anti-inflammatory profile to inflammatory stimuli.
Interestingly, our data did not suggest that neutrophil
phagocytosis contributed to risk of infection. While the
change in neutrophil phagocytosis postoperatively was
statistically significant, and consistent with observations
after abdominal surgery,32 the levels of phagocytosis
reported here are well within the normal range. This is
in striking contrast to the situation in critically ill
Figure 1 Postoperative changes in blood monocyte subsets. (A) Serial flow cytometry plots from a single representative patient,
illustrating the quantification strategy (as outlined in the Methods section). Mononuclear cells were obtained from whole blood
subjected to dextran sedimentation and discontinuous percoll gradients. The monocyte population was identified by gating on
characteristic forward scatter and side scatter appearances. Within this gate, HLA-DR expressing cells were identified, and in this
population staining for CD14 and CD16 defined ‘classical’ CD14++CD16− monocytes (Q3, bottom right quadrant), ‘intermediate’
CD14++CD16+ monocytes (Q2, top right quadrant) and ‘non-classical’ CD14+CD16++ monocytes (Q1, top left quadrant). As an
additional quality control, expression of CCR2 and CX3CR1 was assessed, to confirm that the expected expression pattern of
these receptors within each monocyte subset was observed. (B) Serial monocyte subset counts in blood. Median values are
shown with the IQR in brackets. Paired t tests were used to determine postoperative change, n=39 preoperatively, n=38 at 24 h
and n=27 at 48 h.
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cohorts of patients, where reduced neutrophil phago-
cytosis (<50% of neutrophils ingesting 2 or more
zymosan particles) is independently associated with
increased risk of nosocomial infection.33
A unique opportunity to study early innate responses in
the lung was also afforded by this study. Previous studies
have described pulmonary inflammation after thoracic
surgery using serial BAL.34–36 However, they have gener-
ally been confounded by short intervals between sam-
pling, and by relatively small volumes of instillate. The
present study overcame these limitations. Our results
confirm that the lung contralateral to the operated
tumour is inflamed extremely early in the course of thor-
acic surgery (ie, within the first couple of hours), with
increased neutrophil influx and protein leak across the
alveolar-capillary membrane. This effect may be partly
attributable to one lung ventilation, which has been
shown to induce inflammatory effects in the lung.35 One-
lung ventilation was used in all patients in this study.
Interestingly, only the preoperative BAL cell count
Table 3 Postoperative changes in BAL fluid
Preoperative BALF Postoperative BALF p Value
Total Protein, μg/mL (IQR) 118 (68.0–188) 187 (94.3–264) 0.029
Leucocyte count, millions/mL (IQR) 0.10 (0.07–0.17) 0.18 (0.09–0.31) 0.012
Macrophages/monocytes, % (IQR) 93 (75–96) 84 (45–92) 0.232
Neutrophils, % (IQR) 4 (2–23.5) 13 (3–49) 0.176
Lymphocytes, % (IQR) 2 (1–3) 3 (1–4) 0.259
Other leucocyte, % (IQR) <1 (0) <1 (0) 1
IL-10, pg/mL (IQR) 0 (0.1–0.99) 0.77 (0–2.07) 0.018
IL-1β, pg/mL (IQR) 1.14 (0–7.59) 6.22 (1.50–24.58) 0.002
IL-6, pg/mL (IQR) 4.67 (1.08–10.71) 17.71 (4.29–45.7) <0.0005
IL-8, pg/mL (IQR) 114 (61.6–275) 258 (95.7–733) 0.017
BAL was always performed in the non-operated lung. The preoperative and postoperative BALs were performed in different lung segments.
Data are presented as median and IQR, while statistical analysis was by paired Student t test. Total protein and differential leucocyte counts,
n=33. Total leucocyte count, n=36. Cytokine analysis, n=35.
BAL, bronchoalveolar lavage; BALF, BAL fluid.
Table 4 Associations with postoperative pneumonia
Panel A
Marker Pneumonia No pneumonia p Value
Preoperative leucocyte count in blood (×109/L) 9.1 (8.4–11.2) 7.9 (6.7–9.5) 0.007
Preoperative blood neutrophils (×109/L) 5.8 (5.1–6.9) 4.7 (4.1–5.7) 0.015
Preoperative BAL leucocyte count (millions/mL) 0.14 (0.1–0.2) 0.08 (0.0–0.1) 0.012
Serum IL-8 (48 h; pg/mL) 17.4 (13.2–21.1) 14.5 (10.5–16.8) 0.031
Serum TNF (48 h; pg/mL) 6.9 (4.0–10.3) 7.5 (5.3–9.2) 0.023
Monocyte supernatant IL-12 (preoperative; pg/mL/μg) 0.140 (0.1–0.2) 0.187 (0.1–0.3) 0.008
Monocyte supernatant IL-10 (24 h; pg/mL/μg) 3.2 (2.1–4.7) 1.4 (0.5–2.4) 0.014
Monocyte supernatant IL-6 (24 h; pg/mL/μg) 525 (347–823) 298 (115–532) 0.040
Monocyte supernatant IL-6 (48 h; pg/mL/μg) 616 (397–778) 315 (176–607) 0.014
Monocyte supernatant IL-8 (48 h; pg/mL/μg) 2525 (2127–3448) 2298 (1043–2719) 0.040
Panel B
Biomarker
Optimum Fisher
RR (95% CI) Positive LR Negative LRCut point p Value
Pre-op blood neutrophils (×109/L) 5.04 0.02 3.3 (1.1 to 10.1) 2.04 (1.17–3.57) 0.32 (0.11–0.99)
Pre-op BAL white cell count (millions/mL) 0.104 0.0093 3.4 (1.3 to 9.0) 2.55 (1.25–5.19) 0.40 (0.17–0.94)
Pre-op monocyte supernatant IL-12 (pg/mL/μg) 0.147 0.0168 3.0 (1.2 to 7.3) 2.78 (1.25–6.20) 0.46 (0.22–0.96)
Monocyte supernatant IL-10 (24 h; pg/mL/μg) 1.988 0.0072 4.1 (1.3 to 12.3) 2.55 (1.35–4.83) 0.31 (0.11–0.87)
Monocyte supernatant IL-6 (24 h; pg/mL/μg) 414 0.02 3.1 (1.2 to 8.1) 2.32 (1.19–4.51) 0.41 (0.17–0.98)
(A) Factors associated with postoperative pneumonia. Data are presented as medians with IQR in brackets. Statistical analysis was performed
using an unpaired Student t test. Only factors that were significantly different in the two groups are shown. n=40 for all comparisons except
preoperative BAL, serum and monocyte supernatant experiments at 48 h, where n=38.
(B) Predictive strength of biomarkers associated with pneumonia. The optimum cut point to dichotomise each parameter was determined by
Youden’s index. n=40 for all comparisons except preoperative BAL where n=38.
For both (A) and (B), monocyte supernatant values refer to monocytes stimulated ex vivo with LPS.
BAL, Bronchoalveolar lavage; LPS, lipopolysaccharide; LR, likelihood ratio; Pre-op, preoperative; RR, relative risk; TNF, tumour necrosis factor.
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appeared to predict postoperative pneumonia (table 4
panel B), and it remains to be determined whether the
postoperative inflammatory response in the lung is exag-
gerated in patients who have a high preoperative cell
count in BAL fluid.
We should emphasise again that our analysis of factors
associated with postoperative pneumonia in this popula-
tion was exploratory and hypothesis generating. As
described above, the apparent association with the IL-10
release from monocytes is intriguing, but it must be
emphasised that this is an isolated finding. There was
not a frank CARS response in these patients. The inevit-
able conclusions are, first, that the contribution of, and
dynamic interplay between, proinflammatory and anti-
inflammatory cascades are likely to contribute to the
pulmonary inflammation observed, and second, that our
findings require validation in larger and multicentre
cohorts. However, we believe they represent an import-
ant first step in this regard, and add to the list of factors
potentially associated with complications after thoracic
surgery, such as low diffusing capacity for carbon mon-
oxide, certain gene polymorphisms and inflammatory
parameters.37–39 Ultimately, this work was based on the
expectation that a greater understanding of the innate
immune processes associated with postoperative compli-
cations may allow stratified approaches to management
(based on the expectation of postoperative risk) and/or
the evolution of novel strategies for the prevention of
complications through manipulation of the innate
immune response.
When considering our data on postoperative risk, it
must be kept in mind that our definition of ‘pneumo-
nia’ is in the strict sense of ‘alveolar inflammation’, and
the radiological consolidation could represent infiltra-
tion of inflammatory cells without infection. We did not
judge it ethical to request a further routine BAL for
microbiological culture in recovering surgical patients.
Nevertheless, our criteria for pneumonia were prede-
fined, alveolar shadowing on CXR was judged by an
experienced thoracic radiologist, and 8 of the 14
patients with ‘pneumonia’ did have bacterial pathogens
isolated from the sputum as part of their routine clinical
care. Therefore, while we cannot be certain that all
patients with ‘pneumonia’ had bacterial infection, we
can be confident that they had alveolar inflammation. It
is also important to emphasise that all patients with
pneumonia made a good recovery.
In addition, a number of potential limitations should
be considered when interpreting our data. Our sample
size was small, as we deliberately concentrated on what we
believe to be by far the most comprehensive and detailed
serial analysis within individual patients in this setting.
Our findings provide initial insights but require confirm-
ation in larger cohorts. Also, most of our patients had
lung cancer, a burden of tobacco exposure and variable
medications including statins, all of which may potentially
influence innate immunity. Nevertheless, these factors
are likely to be characteristic of, and relatively consistent
in, populations of patients being worked up for lung
cancer resection, and so the data remain relevant in that
specific context. Furthermore, as with all functional
studies using neutrophils and monocytes, we cannot be
certain that the ex vivo monocyte responsiveness data are
representative of biological activity in vivo. In addition,
our protocol did not mandate a standardised anaesthetic
approach in all patients (anaesthesia was entirely at the
discretion of the anaesthetic team). While we are
unaware of any significant variations in anaesthetic prac-
tice, potential variations could theoretically impact par-
ticularly on our BAL data.
In summary, thoracic surgery mobilises circulating
classical and intermediate monocytes, and is associated
with the release of proinflammatory cytokines from
blood monocytes in response to inflammatory stimuli.
Monocyte responsiveness to LPS and preoperative
levels of leucocytosis appears to be associated with a
risk of postoperative pneumonia, but this requires
further characterisation and confirmation in larger
cohorts.
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